Abstract
Latino Americans are a rapidly growing ethnic group in the United States but studies of glioblastoma in this population are limited. We have evaluated characteristics of 21,184 glioblastoma patients from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. This SEER data from 2001 to 2011 draws from 28% of the U.S. population. Latinos have a lower incidence of GBM and present slightly younger than non-Latino Whites. Cubans present at an older age than other Latino sub-populations. Latinos have a higher incidence of giant cell glioblastoma than non-Latino Whites while the incidence of gliosarcoma is similar. Despite lower rates of radiation therapy and greater rates of sub-total resection than non-Latino Whites, Latinos have better 1 and 5 year survival rates. SEER does not record chemotherapy data. Survivals of Latino sub-populations are similar with each other. Age, extent of resection, and the use of radiation therapy are associated with improved survival but none of these variables are sufficient in a multivariate analysis to explain the improved survival of Latinos relative to non-Latino Whites. As molecular data is not available in SEER records, we studied the MGMT and IDH status of 571 patients from a UCLA database. MGMT methylation and IDH1 mutation rates are not statistically significantly different between non-Latino Whites and Latinos. For UCLA patients with available information, chemotherapy and radiation rates are similar for non-Latino White and Latino patients, but the latter have lower rates of gross total resection and present at a younger age.
Similar content being viewed by others
References
American Cancer Society (2016) Brain and spinal cord tumors in adults. http://www.cancer.org/cancer/braincnstumorsinadults/detailedguide/brain-and-spinal-cord-tumors-in-adults-key-statistics. Accessed 22 Apr 2016
CBTRUS (2012), CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2004–2008 (March 23, 2012 Revision). Source: central brain tumor registry of the United States, Hinsdale, IL
Braganza MZ, Kitahara CM, de González AB et al (2012) Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review. Neuro Oncol 14(11):1316–1324
Neglia JP, Robison LL, Stovall M et al (2006) New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 98(21):1528–1537
Krishnan G, Felini M, Carozza SE et al (2003) Occupation and adult gliomas in the San Francisco bay area. J Occup Environ Med 45(6):639–647
Savitz DA, Loomis DP (1995) Magnetic field exposure in relation to leukemia and brain cancer mortality among electric utility workers. Am J Epidemiol 141(2):123–134
Greig NH, Ries LG, Yancik R et al (1990) Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 82(20):1621–1624
Hess KR, Broglio KR, Bondy ML (2004) Adult glioma incidence trends in the United States, 1977–2000. Cancer 101(10):2293–2299
Chandler KL, Prados MD, Malec M et al (1993) Long-term survival in patients with glioblastoma multiforme. Neurosurgery 32(5):716–720
Müller H, Brock M, Ernst H (1985) Long-term survival and recurrence-free interval in combined surgical, radio and chemotherapy of malignant brain gliomas. Clin Neurol Neurosurg 87(3):167–171
Salford LG, Brun A, Nirfalk S (1988) Ten-year survival among patients with supratentorial astrocytomas grade III and IV. J Neurosurg 69(4):506–509
Thumma SR, Fairbanks RK, Lamoreaux WT et al (2012) Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: A surveillance epidemiology and end results (SEER) population analysis. World J Surg Oncol 10:75
Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459–466
Weathers SP, Gilbert MR (2014) Advances in treating glioblastoma. F1000Prime Rep 2;6:46. doi:10.12703/P646
Kamoshima Y, Motegi H, Terasaka S et al (2012) Analyses of IDH1 mutation and MGMT promoter methylation status for 5 cases of long-term survivors with glioblastoma. No Shinkei Geka 40(2):129–135
Hegi ME, Diserens AC, Gorlia T et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352(10):997–1003
Preston-Martin S (1989) Descriptive epidemiology of primary tumors of the brain cranial nerves and cranial meninges in Los Angeles County. Neuroepidemiology 8(6):283–295
Robertson JT, Gunter BC, Somes GW (2002) Racial differences in the incidence of gliomas: a retrospective study from Memphis, Tennessee. Br J Neurosurg 16(6):562–566
Barnholtz-Sloan JS, Maldonado JL, Williams VL et al (2007) Racial/ethnic differences in survival among elderly patients with a primary glioblastoma. J Neuro-Oncol 85(2):171–180
Deorah S, Lynch CF, Sibenaller ZA et al (2006) Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurg Focus 20(4):E1
Chakrabarti I, Cockburn M, Cozen W et al (2005) A population-based description of glioblastoma multiforme in Los Angeles County, 1974–1999. Cancer 104(12):2798–2806
Colby SL, Ortman JM (2015) Projections of the size and composition of the U.S. population: 2014 to 2060 population, estimates and projections current population: U.S. department of commerce economics and statistics administration, U.S. census bureau, census.gov, P25–1143
Curry WT Jr, Barker FG 2nd (2009) Racial, ethnic and socioeconomic disparities in the treatment of brain tumors. J Neurooncol 93(1):25–39
Murthy VH, Krumholz HM (2004) Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291(22):2720–2726
NAACCR Race and Ethnicity Work Group. (2009) NAACCR guideline for enhancing hispanic/latino identification: revised NAACCR hispanic/latino identification algorithm [NHIA v2.2]. North American Association of Central Cancer Registries, Springfield
McLendon RE, Robinson JS Jr, Chambers DB et al (1985) The glioblastoma multiforme in Georgia, 1977–1981. Cancer 56(4):894–897
Barnholtz-Sloan JS, Sloan AE, Schwartz AG (2003) Relative survival rates and patterns of diagnosis analyzed by time period for individuals with primary malignant brain tumor, 1973–1997. J Neurosurg 99(3):458–466
Dubrow R, Darefsky AS (2011) Demographic variation in incidence of adult glioma by subtype, United States, 1992–2007. BMC Cancer 11:325
Brown M, Schrot R, Bauer K et al (2009) Incidence of first primary central nervous system tumors in California, 2001–2005: children, adolescents and teens. J Neuro-Oncol 94(2):263–273
Koshy M, Villano JL, Dolecek TA et al (2012) Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neuroonco 107(1): 207–212
Burger PC, Green SB (1987) Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 59(9):1617–1625
Sneed PK, Prados MD, McDermott MW et al (1995) Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost. Neurosurgery 36(5):898–903
Krex D, Klink B, Hartmann C et al (2007) Long-term survival with glioblastoma multiforme. Brain 130(Pt 10):2596–2606
Laws ER, Parney IF, Huang W et al (2003) Glioma outcomes investigators. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the glioma outcomes project. J Neurosurg 99(3):467–473
Simpson JR, Horton J, Scott C et al (1993) Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26(2):239–244
Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95(2):1908
Singal V, Singal AK, Kuo YF (2012) Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis. J Cancer Res Clin Oncol 138(4):715–722
McCann J, Artinian V, Duhaime L et al (2005) Evaluation of the causes for racial disparity in surgical treatment of early stage lung cancer. Chest 128(5):3440–3446
Terplan M, Schluterman N, McNamara EJ et al (2012) Have racial disparities in ovarian cancer increased over time? An analysis of SEER data. Gynecol Oncol 125(1):19–24
Walker MD, Strike TA, Sheline GE (1979) An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5(10):1725–1731
Stupp R, Dietrich PY, Kraljevic SO et al (2002) Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 20(5):1375–1382
Aizer AA, Ancukiewicz M, Nguyen PL et al (2014) Underutilization of radiation therapy in patients with glioblastoma: predictive factors and outcomes. Cancer 120(2):238–243
Walker GV, Li J, Mahajan A et al (2012) Decreasing radiation therapy utilization in adult patients with glioblastoma multiforme: a population-based analysis. Cancer 118(18):4538–4544
Punglia RS, Weeks JC, Neville BA et al (2006) Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women. Int J Radiat Oncol Biol Phys 66(1):56–63
Bradley CJ, Given CW, Roberts C (2002) Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 94(7):490–496
Kozak KR, Moody JS (2009) Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis. Neuro Oncol 11(6):833–841
Wang T, Jani A, Saad S et al (2014) RT-36 Oncologic outcome of Hispanic patients with glioblastoma treated with radiotherapy. Neuro-Oncol 16(Suppl 5):v195. doi:10.1093/neuonc/nou270.32
Lopez-Gonzalez MA, Sotelo J (2000) Brain tumors in Mexico: characteristics and prognosis of glioblastoma. Surg Neurol 53(2):157–162
National Cancer Institute Surveillance, Epidemiology, End Result Program (2016) Number of persons by race and hispanic ethnicity for SEER participants. http://seer.cancer.gov/registries/data.html. Accessed 09 Aug 2016
Acknowledgements
This work was supported by the Art of the Brain Foundation and Henry E. Singleton Cancer Fund.
Author information
Authors and Affiliations
Corresponding author
Additional information
Maryam Shabihkhani and Donatello Telesca have contributed equally.
Rights and permissions
About this article
Cite this article
Shabihkhani, M., Telesca, D., Movassaghi, M. et al. Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma. J Neurooncol 132, 351–358 (2017). https://doi.org/10.1007/s11060-017-2377-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-017-2377-0